Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran.

Acta tropica - 1 Mar 2009

Zakeri Sedigheh, Razavi Sepand, Djadid Navid Dinparast

Abstract excerpt

The leading candidates for a Transmission Blocking Vaccine (TBV) in Plasmodium vivax parasite are the ookinete surface protein 25 (Pvs25) and Pvs28, which their phase I clinical trial is ongoing. Therefore, we carried out survey of polymorphisms of the pvs25 and pvs28 genes in P. vivax populations that are circulating in the two malaria areas of contrasting endemicity in Iran, before field application of the TBV....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Protozoan
Share to Antigens, Surface

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to DNA, Protozoan

Share to Malaria Vaccines

Share to Malaria, Vivax

Share to Plasmodium vivax

Share to Sequence Homology

Source

Identifiers

PMID: 18950597
DOI: 10.1016/j.actatropica.2008.09.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran.PMID 18950597Read ↗

Genetic diversity of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax isolates from China.Semantic proximity Read ↗

Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China.Semantic proximity Read ↗

Sequence Polymorphism in Two Novel Plasmodium vivax Ookinete Surface Proteins, Pvs25 and Pvs28, That Are Malaria Transmission-blocking Vaccine CandidatesSemantic proximity Read ↗

Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent.Semantic proximity Read ↗

A rapid genotyping method for the vivax malaria transmission-blocking vaccine candidates, Pvs25 and Pvs28.Semantic proximity Read ↗

Genetic diversity and natural selection of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax Myanmar isolatesSemantic proximity Read ↗

Genetic diversity of transmission-blocking vaccine candidate Pvs48/45 in Plasmodium vivax populations in China.Semantic proximity Read ↗

Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivaxSemantic proximity Read ↗

Genetic diversity in the transmission-blocking vaccine candidate Plasmodium vivax gametocyte protein Pvs230 from the China-Myanmar border area and central Myanmar.Semantic proximity Read ↗

Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45.Semantic proximity Read ↗

Limited genetic diversity in the global Plasmodium vivax Cell traversal protein of Ookinetes and Sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development.Semantic proximity Read ↗

Genetic Diversity of Circumsporozoite Surface Protein of Plasmodium vivax from the Central Highlands, VietnamSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.